In a clinical trial, the highest dose of orforglipron led to 11.2 percent weight loss at 72 weeks
Gastrointestinal Symptoms : nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, heartburn, and impaired motility Secretomotor Symptoms : difficulty sweating, tearing, and other fluid production (dry eyes, dry mouth, difficulty swallowing, dry skin)
"Our community is incredibly focused on metabolic health, specifically looking for the latest and greatest innovation and research," Lemme cofounder Simon Huck said
This hormone helps regulate blood sugar, slow the movement of food out of the stomach and reduce appetite
Analyzing the historical market, estimating the current market, and forecasting the future market of the global GLP-1 Analogues market were the three major steps undertaken to create and analyze the adoption of GLP-1 Analogues in major regions globally